Trade BioNTech BNTX

BioNTech live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 May 27, 12:27

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting | The Manila Times

BioNTech SE
Webhose 2025 May 27, 12:18

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, "

BioNTech SE
Webhose 2025 May 27, 07:00

AI-Driven mRNA Therapeutics Market Development Accelerated by AI Integration in Drug Design Delivery and Scalable Manufacturing

BioNTech SE
Webhose 2025 May 27, 00:00

Cambridge R&D Centre being created by BioNTech in £1bn UK spree

BioNTech SE
Webhose 2025 May 26, 09:00

2,061 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by GF Fund Management CO. LTD.

BioNTech SE
Webhose 2025 May 26, 07:21

BioNTech SE (NASDAQ:BNTX) Stake Cut by Bank of America Corp DE

BioNTech SE
Webhose 2025 May 24, 14:22

JPMorgan Chase & Co. Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech SE
Webhose 2025 May 24, 12:10

BioNTech's (BNTX) "Buy" Rating Reaffirmed at HC Wainwright

BioNTech SE
Webhose 2025 May 23, 05:58

BioNTech SE (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2025 May 21, 19:26

BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion

BioNTech SE
Webhose 2025 May 21, 10:42

BioNTech SE (NASDAQ:BNTX) Shares Sold by Voloridge Investment Management LLC

BioNTech SE
Webhose 2025 May 19, 08:58

OMERS ADMINISTRATION Corp Purchases New Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 19, 01:06

AIM Vaccine's Next-Gen mRNA Shingles Vaccine Secures Clinical Approvals in Both PRC and U.S. ,mRNA Platform Advantages Shine Through | The Manila Times

BioNTech SE
Webhose 2025 May 18, 10:44

Tema Etfs LLC Acquires New Shares in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 15, 02:06

Bank of America Securities Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider

BioNTech SE
Webhose 2025 May 14, 09:50

Cresset Asset Management LLC Decreases Stock Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 14, 02:00

BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term

BioNTech SE
Webhose 2025 May 12, 09:09

Crestline Management LP Takes $943,000 Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 10, 12:32

Fred Alger Management LLC Sells 35,467 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 09, 09:00

BNP Paribas Financial Markets Takes Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 08, 15:13

Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech SE
Webhose 2025 May 07, 10:45

BioNTech (BNTX) Faces Investor Concerns Amid FDA Leadership Shift | BNTX Stock News

BioNTech SE
Webhose 2025 May 07, 09:52

BioNTech (NASDAQ:BNTX) Price Target Lowered to $132.00 at Morgan Stanley

BioNTech SE
Webhose 2025 May 06, 22:35

BioNTech (BNTX) Stock Declines Amid Leadership Changes and Analyst Downgrade

BioNTech SE
Webhose 2025 May 06, 19:51

BioNTech (BNTX) Shares Tumble as FDA Announces Leadership Change

BioNTech SE
Webhose 2025 May 06, 17:36

BioNTech (BNTX): Citigroup Maintains Rating, Lowers Price Target | BNTX Stock News

BioNTech SE
Webhose 2025 May 06, 12:17

BioNTech SE (NASDAQ:BNTX) Q1 2025 Earnings Call Transcript

BioNTech SE
Webhose 2025 May 06, 11:39

Baker BROS. Advisors LP Invests $5.13 Million in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 May 06, 10:16

BioNTech (BNTX) Target Price Lowered by Citi Analyst Amid Quarte

BioNTech SE
Webhose 2025 May 06, 08:46

BioNTech SE (NASDAQ:BNTX) Shares Sold by Axa S.A.

BioNTech SE
Webhose 2025 May 06, 06:10

BioNTech SE (BNTX) Q1 2025 Earnings Call Highlights: Navigating Challenges and Advancing ...

BioNTech SE
Webhose 2025 May 06, 05:00

Appointments and advancements for May 6, 2025 | BioWorld

BioNTech SE
Webhose 2025 May 06, 04:25

Q1 2025 Biontech SE Earnings Call Transcript

BioNTech SE
Webhose 2025 May 05, 21:56

Health Care Down on Mixed Earnings - Health Care Roundup | Morningstar

BioNTech SE
Webhose 2025 May 05, 18:57

BioNTech (BNTX) Price Target Cut by BofA, Buy Rating Maintained | BNTX Stock News

BioNTech SE
Webhose 2025 May 05, 17:58

BioNTech (BNTX) Sees Price Target Cut Amid Upcoming Catalysts | BNTX Stock News

BioNTech SE
Webhose 2025 May 05, 12:23

BioNTech SE Appoints New CFO to Drive Financial Strategy in Oncology Expansion | BNTX stock news

BioNTech SE
Webhose 2025 May 05, 12:22

BioNTech SE (BNTX) Reports Q1 2025 Financial Results and Strategic Updates | BNTX stock news

BioNTech SE
Webhose 2025 May 05, 12:10

BioNTech says Novartis executive Zapata-Gomez to become CFO

BioNTech SE
Webhose 2025 May 05, 11:45

BioNTech (BNTX) Reveals Q1 Revenue and Advances in Strategic Focus | BNTX Stock News

BioNTech SE
Webhose 2025 May 05, 11:36

BioNTech (BNTX) Reports Q1 Loss, Maintains 2025 Financial Guidance

BioNTech SE
Webhose 2025 May 05, 11:34

BioNTech (BNTX) Welcomes Ramón Zapata-Gomez as New CFO

BioNTech SE
Webhose 2025 May 05, 11:33

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

BioNTech SE
Webhose 2025 May 05, 10:54

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update | The Manila Times

BioNTech SE
Webhose 2025 May 05, 10:45

BioNTech Reports Smaller-Than-Expected Loss, Names New CFO

BioNTech SE
Webhose 2025 May 05, 07:20

BioNTech Q1 Loss Widens, Revenues Down; Confirms FY25 Outlook

BioNTech SE
Webhose 2025 May 05, 07:00

BioNTech SE Q1 25 Earnings Conference Call At 8:00 AM ET

BioNTech SE
Webhose 2025 May 05, 00:00

BNTX Q1 2025 Earnings Report on 5/5/2025

BioNTech SE
Webhose 2025 May 02, 07:53

BioNTech SE (NASDAQ:BNTX) Shares Purchased by CANADA LIFE ASSURANCE Co

BioNTech SE
Webhose 2025 May 01, 12:09

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

BioNTech SE
Webhose 2025 May 01, 10:46

BioNTech (BNTX) Involved in New Vaccine Development Initiative | BNTX Stock News

BioNTech SE
Webhose 2025 Apr 30, 16:17

BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why

BioNTech SE
Webhose 2025 Apr 30, 15:48

Pfizer, BioNTech Fail to Void Alnylam's Covid-Shot Patent Claims

BioNTech SE
Webhose 2025 Apr 30, 09:56

BioNTech (BNTX) Projected to Post Earnings on Monday

BioNTech SE

BioNTech news

Tommy Yap 2025 Mar 04, 16:00

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares
Pfizer shares sink as revenue prospects
Georgy Istigechev 2023 Dec 14, 05:13

Pfizer shares sink on lower COVID revenue prospects

Shares
shutterstock_1781525795.jpg
Zachariah Walker 2023 Feb 14, 09:11

5 Stocks to Fall in Love with this Valentines Day

2021 Aug 24, 08:05

Stocks make further gains as oil bounce carries on

Latest news

Show more
Ghko B 2025 May 28, 16:00

Tariff news update: US trade court blocks Trump “liberation day” tariffs

Stocks
Frances Wang 2025 May 28, 16:00

Crypto market today: How high will Bitcoin get this year?

Cryptocurrencies
Frances Wang 2025 May 28, 16:00

Joby Stock Is Climbing Today: what’s going on with Joby Aviation?

Stocks
Tommy Yap 2025 May 28, 16:00

Morning Note: USD Jumps on Tariff Block; NVIDIA's Strong Q1; Costco Earnings Due

Morning Note Forex Tech
Frances Wang 2025 May 27, 16:00

GOOGL Share Price Analysis: Why Alphabet Stock Is Up Today?

Stocks
Frances Wang 2025 May 27, 16:00

Stock market today: Hang Seng Dips, Nikkei Gains. Dow jumps

Stocks
Tommy Yap 2025 May 27, 16:00

Morning Note: RBNZ Eases Policy; Aussie Inflation Surprises; Tesla Struggles in Europe

Morning Note
Tommy Yap 2025 May 26, 16:00

Morning Note: Gold Awaits Fed Clues; Japan Fiscal Strain; SNB Hints More Cuts

Morning Note Commodities

Info

Spread

0.7548

Spread (%)

0.7774 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

23721971712

instr__shares_outstand

240392992

instr__earnings_date

0000-00-00

instr__dividend_date

2022-06-17

instr__ex_dividend_date

2022-06-02

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-3.61

instrument_learn_more

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.
Markets.com Bonus Trading

related_instruments

view_all_instruments

latest_education_articles

Show more
Trustpilot